Rifaximin for the prevention and treatment of hepatic encephalopathy: a systematic review with meta-analyses of randomised controlled trials

Kimer, N; Gluud, LL; Morris, RW; Morgan, MY; (2017) Rifaximin for the prevention and treatment of hepatic encephalopathy: a systematic review with meta-analyses of randomised controlled trials. Presented at: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands.

from #ENT-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2uIWY70